- Home
- PMCB vs SCNX Comparison
PMCB vs SCNX Comparison
Compare PMCB & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- SCNX
- Stock Information
- Founded
- PMCB 1996
- SCNX 2010
- Country
- PMCB United States
- SCNX United States
- Employees
- PMCB N/A
- SCNX N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- SCNX Other Pharmaceuticals
- Sector
- PMCB Health Care
- SCNX Health Care
- Exchange
- PMCB Nasdaq
- SCNX Nasdaq
- Market Cap
- PMCB 11.4M
- SCNX 59.2M
- IPO Year
- PMCB N/A
- SCNX 2020
- Fundamental
- Price
- PMCB $1.64
- SCNX $7.58
- Analyst Decision
- PMCB
- SCNX
- Analyst Count
- PMCB 0
- SCNX 0
- Target Price
- PMCB N/A
- SCNX N/A
- AVG Volume (30 Days)
- PMCB 14.2K
- SCNX 13.8K
- Earning Date
- PMCB 12-31-2024
- SCNX 02-10-2025
- Dividend Yield
- PMCB N/A
- SCNX N/A
- EPS Growth
- PMCB N/A
- SCNX N/A
- EPS
- PMCB 0.74
- SCNX 3.55
- Revenue
- PMCB N/A
- SCNX N/A
- Revenue This Year
- PMCB N/A
- SCNX $1,085.75
- Revenue Next Year
- PMCB N/A
- SCNX N/A
- P/E Ratio
- PMCB $2.21
- SCNX $3.23
- Revenue Growth
- PMCB N/A
- SCNX 166.67
- 52 Week Low
- PMCB $1.39
- SCNX $3.69
- 52 Week High
- PMCB $2.58
- SCNX $44.56
- Technical
- Relative Strength Index (RSI)
- PMCB 45.24
- SCNX N/A
- Support Level
- PMCB $1.60
- SCNX N/A
- Resistance Level
- PMCB $1.69
- SCNX N/A
- Average True Range (ATR)
- PMCB 0.11
- SCNX 0.00
- MACD
- PMCB -0.00
- SCNX 0.00
- Stochastic Oscillator
- PMCB 40.00
- SCNX 0.00
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.